1. Artesunate-amodiaquine (AA) treated Ebola patients had a significantly lower risk of death than artemether-lumefantrine (AL) treated patients. 2. The effect reduced mortality associated with AA treatment in comparison to AL was attenuated when the study population was stratified a positive malaria test. Evidence Rating Level: 2 (Good) Study Rundown: Since the outbreak
↧
